Sickle cell disease and readmissions rates after lower extremity arthroplasty: a multistate analysis 2007-2014

被引：8

作者：

Chen, Yuefan ^{[1
]}

White, Robert S. ^{[2
]}

Tangel, Virginia ^{[3
]}

Noori, Selaiman A. ^{[4
]}

Gaber-Baylis, Licia K. ^{[3
]}

Mehta, Neel D. ^{[1
]}

Pryor, Kane O. ^{[1
]}

机构：

[1] Weill Cornell Med, Dept Anesthesiol, 525 East 68th St, New York, NY 10065 USA

[2] Weill Cornell Med, Dept Anesthesiol, New York Presbyterian Hosp, 525 East 68th St, New York, NY 10065 USA

[3] Weill Cornell Med, Dept Anesthesiol, Ctr Perioperat Outcomes, 428 East 72nd St,Ste 800A, New York, NY 10021 USA

[4] Cleveland Clin, Inst Anesthesiol, Dept Pain Management, 9500 Euclid Ave,C-25, Cleveland, OH 44195 USA

来源：

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2019年 / 8卷 / 06期

关键词：

hematology; observational research; outcomes research; TOTAL HIP-ARTHROPLASTY; LENGTH-OF-STAY; CARE UTILIZATION; HEALTH-CARE; REPLACEMENT; OUTCOMES; OSTEONECROSIS; KNEE; COMORBIDITIES; EXPENDITURES;

D O I：

10.2217/cer-2018-0098

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Aim: To compare readmission rates between patients with sickle cell disease (SCD) and non-sickle cell disease undergoing total hip and knee arthroplasty (THA and TKA). Methods: Identified adult patients who underwent THA or TKA from 2007 to 2014 in California, Florida, New York, Maryland and Kentucky using a multistate database. Outcomes were 30- and 90-day readmission rates, mortality, complications, length of stay and hospital charges. Logistic regression models were used for analysis. Results: Compared with non-sickle cell disease patients following TKA and THA, SCD patients had higher odds of 30-(odds ratio [OR]: 3.79) and 90-day readmissions (OR: 4.15), mortality (OR: 6.54), more complications, longer length of stay, and higher total charges. Conclusion: Following TKA and THA, SCD is associated with higher readmissions and worse outcomes.

引用

页码：403 / 422

页数：20

共 45 条

[1] HIP-ARTHROPLASTY IN PATIENTS WITH SICKLE-CELL HEMOGLOBINOPATHY
ACURIO, MT
FRIEDMAN, RJ
[J]. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1992, 74 (03): : 367 - 371
[2] Surgical and obstetric outcomes in adults with sickle cell disease
Adam, Soheir
Jonassaint, Jude
Kruger, Hillary
Kail, Melanie
Orringer, Eugene P.
Eckman, James R.
Ashley-Koch, Allison
Telen, Marilyn J.
De Castro, Laura M.
[J]. AMERICAN JOURNAL OF MEDICINE, 2008, 121 (10) : 916 - 921
[3] Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California
Adesina, Oyebimpe
Brunson, Ann
Keegan, Theresa H. M.
Wun, Ted
[J]. BLOOD ADVANCES, 2017, 1 (16) : 1287 - 1295
[4] Total hip replacement in sickle cell disease
Al-Mousawi, F
Malki, A
Al-Aradi, A
Al-Bagali, M
Al-Sadadi, A
Booz, MMY
[J]. INTERNATIONAL ORTHOPAEDICS, 2002, 26 (03) : 157 - 161
[5] Sickle Cell Disease-Related Pediatric Medical Expenditures in the US
Amendah, Djesika D.
Mvundura, Mercy
Kavanagh, Patricia L.
Sprinz, Philippa G.
Grosse, Scott D.
[J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2010, 38 (04) : S550 - S556
[6] [Anonymous], 2018, OVERVIEW STATE INPAT
[7] [Anonymous], 2018, REQUIREMENTS PUBLISH
[8] Racial/Ethnic and Socioeconomic Disparities in Total Knee Arthroplasty 30-and 90-Day Readmissions: A Multi-Payer and Multistate Analysis, 2007-2014
Arroyo, Noelle S.
White, Robert S.
Gaber-Baylis, Licia K.
La, Melvin
Fisher, Andrew D.
Samaru, Mahendranauth
[J]. POPULATION HEALTH MANAGEMENT, 2019, 22 (02) : 175 - 185
[9] Barrett, 2006, HEALTHCARE COST UTIL
[10] Discordance between Self-Report and Genetic Confirmation of Sickle Cell Disease Status in African-American Adults
Bean, Christopher J.
Hooper, W. Craig
Ellingsen, Dorothy
DeBaun, Michael R.
Sonderman, Jennifer
Blot, William J.
[J]. PUBLIC HEALTH GENOMICS, 2014, 17 (03) : 169 - 172

← 1 2 3 4 5 →